HHS marches forward to enhance drug price transparency

21 May 2019 - HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to ...

Read more →

Official Information Act response: adrenaline auto-injector cost utility analysis

20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...

Read more →

Could drug price transparency raise prices? These lobbyists and lawmakers think so.

21 May 2019 - Objections made on disclosing rebates and revealing data about free samples. ...

Read more →

The global battle over high drug prices

21 May 2019 - Western countries, as well as poor ones, are demanding transparency in the cost of drugs. ...

Read more →

Push for drug pricing transparency strikes a nerve with industry

19 May 2019 - Ahead of the World Health Assembly in Geneva, an Italian draft resolution to end secrecy around ...

Read more →

CMS takes action to lower prescription drug prices and increase transparency

16 May 2019 - Final rule modernises the Medicare Advantage & Medicare Part D programs. ...

Read more →

Drug prices in TV ads: how transparent are they?

15 May 2019 - A website launched by pharmaceutical giant Eli Lilly earlier this year leads with a daunting statement ...

Read more →

Grandstanding, not real change: why drug prices in TV ads will be confusing and irrelevant

13 May 2019 - In a fit of hubris, President Trump believes he is making drug makers “come clean” by ...

Read more →

Drug prices will soon appear in many US TV ads

8 May 2019 - Alex Azar, the secretary for health and human services, announced the change, which has been pushed by ...

Read more →

PHARMAC sheds a little more light on procedures in savvy political move

1 May 2019 - Steve Maharey has just secured special status on David Clark's Christmas card list. ...

Read more →

Proposal to decline inactive applications

29 April 2019 - To help make its decision-making process clearer, PHARMAC is seeking feedback on a proposal to make ...

Read more →

PHARMAC proposes to give more clarity about funding decisions

29 April 2019 - An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and ...

Read more →

Drug makers reveal list prices online after pressure from Trump

18 April 2019 - Administration wants companies to put prices in their TV ads. ...

Read more →

At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices

13 April 2019 - WHO to continue to facilitate countries’ information-sharing to improve transparency on prices. ...

Read more →

1 April 2019 price disclosure confirmed prices

1 April 2019 - Confirmed 1 April 2019 prices resulting from the 2019 April cycle of price disclosure have now been ...

Read more →